California Public Employees Retirement System’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-113,060
| Closed | -$3.16M | – | 3020 |
|
2021
Q1 | $3.16M | Sell |
113,060
-24,277
| -18% | -$679K | ﹤0.01% | 1717 |
|
2020
Q4 | $3.89M | Sell |
137,337
-6,798
| -5% | -$193K | ﹤0.01% | 1569 |
|
2020
Q3 | $3.62M | Buy |
144,135
+16,853
| +13% | +$424K | ﹤0.01% | 1461 |
|
2020
Q2 | $3.11M | Buy |
127,282
+33,282
| +35% | +$813K | ﹤0.01% | 1521 |
|
2020
Q1 | $1.39M | Buy |
94,000
+5,900
| +7% | +$87.3K | ﹤0.01% | 1804 |
|
2019
Q4 | $1.43M | Buy |
88,100
+19,865
| +29% | +$322K | ﹤0.01% | 2192 |
|
2019
Q3 | $887K | Buy |
68,235
+19,135
| +39% | +$249K | ﹤0.01% | 2334 |
|
2019
Q2 | $637K | Sell |
49,100
-2,655
| -5% | -$34.4K | ﹤0.01% | 2421 |
|
2019
Q1 | $816K | Hold |
51,755
| – | – | ﹤0.01% | 2331 |
|
2018
Q4 | $1.04M | Buy |
+51,755
| New | +$1.04M | ﹤0.01% | 2177 |
|
2016
Q1 | – | Sell |
-10,600
| Closed | -$362K | – | 3608 |
|
2015
Q4 | $362K | Buy |
+10,600
| New | +$362K | ﹤0.01% | 2947 |
|
2014
Q4 | – | Sell |
-15,769
| Closed | -$305K | – | 3837 |
|
2014
Q3 | $305K | Buy |
15,769
+5,698
| +57% | +$110K | ﹤0.01% | 3217 |
|
2014
Q2 | $342K | Buy |
+10,071
| New | +$342K | ﹤0.01% | 3193 |
|